- Birth name
Xu Shaoyong (徐邵雍)
Business magnate, investor
- Known for
Founder and executive chair of Zhupao
- Net worth
¥6.45 trillion as of September 2049
Chinese Communist Party (CCP)
Zhenxi Hai (2042 -
Xu Xuejing (born 2044)
Xu Shaoyong (徐邵雍, born August 29th 1997)
is a Chinese business magnate, politician, investor, philanthropist, and the founder and executive chair of the Chinese technology conglomerate Zhupao. With a net worth of ¥6.45 trillion, he is the wealthiest person in the world.
Born and raised in Beijing, Xu started working at Pinduoduo in 2020, where he supervised several rural outreach and contactless delivery initiatives. Xu left Pinduoduo in 2024 to found Zhupao as a system integration company focused on Drupal, later expanding it to become one of China’s foremost providers of cloud computing, artificial intelligence (AI), and neural colloids.
In 2040, Xu entered Zhupao into a multilateral cooperation strategy with the Chinese Communist Party (CCP) and the World Health Organisation (WHO) to develop G6 in response to the CMD pandemic. Often referred to as China’s paramount leader, Xu
is considered a global ambassador for business and technology
Table of contents
Early life and education
Xu Shaoyong was born in Beijing, China on August 29th 1997 as the youngest of two sons. His father, Xu Jiahai, is a prominent economist and his mother, Wei Yiqin, was a salesperson at a department store. He gained a bachelor’s degree in Arts from the Beijing Forestry University‘s (BFU) School of Foreign Languages in 2018. Through the BFU’s partnership with Birkbeck University, Xu travelled to London City to complete a two-year postgraduate programme in Intercultural Communication for Business and Professions. In his spare time, he taught himself how to design websites, first using Wordpress and later switching to Drupal. 
In September 2020, Xu entered a Pinduoduo hiring round at the urging of a friend working as a technical engineer on the company’s mobile platform. He applied for a marketing position, but was instead offered to join the support team for Duo Duo University, a programme created in 2019 to provide training sessions to farmers selling their products directly on Pinduoduo. Xu moved to Shanghai and helped design courses in e-commerce, finance, business operations, and digital marketing.
In February 2024, Xu left Pinduoduo and founded Zhupao as a limited company focused on Drupal-oriented system integration solutions. Giving himself the title of CEO, Xu rented office space in Shanghai and recruited developers from the Chinese Drupal community to create business-agile data management solutions across all major platforms.
In October 2024, Xu launched a customisable artificial intelligence (AI) assistant with a Drupal-based user interface (UI) that uses natural language processing (NLP) to provide services such as personalised discovery and recommendation algorithms, conversational interaction, and self-optimisation. The AI assistant’s default consumer-facing avatar of a smiling piglet proved so popular with clients that Xu adopted it as Zhupao’s official mascot in January 2025, naming it Zōng and encouraging its front end use with discounted licensing prices. Zōng has since become one of the most popular and instantly recognisable pop culture icons in the world. 
After posting revenues surpassing ¥150 million in February 2026, Xu created a second Zhupao development centre and cloud computing division in Beijing. When Pinduoduo licensed the use of Zhupao’s AI assistant to capitalise on Zōng’s growing popularity, Xu took on his former employer as a client to integrate augmented reality (AR) applications into its social media platform. During Zhupao’s 2027 earnings call, Xu announced the launch of Zhupay (猪付), a digital wallet and payment service, and Zhupao’s acquisition of Apprise, a Hangzhou-based AI company.
In September 2028, Xu finalised a months-long negotiation with Pinduoduo CEO Chen Lei. With his company unable to turn a profit due to an excessive burn rate and the market dominance of Alibaba Group, Chen agreed to establish Pinduoduo as an e-commerce division of Zhupao to benefit from its brand recognition. When the deal was officially approved as a merger, Xu transitioned to the role of Zhupao’s executive chair while installing Chen as CEO, which had been part of their agreement.
In February 2031, Xu announced his intention to take Zhupao public with an initial public offering (IPO) on the STAR Market. This came after the ban on new IPOs, which was put in place during the Second Sino-Indian War, was lifted on February 23rd 2031. Xu launched an IPO promotion campaign with Zōng at the centre, ultimately raising over ¥300 billion for a 5% stake in the company. The full market value was exercised on completion, becoming the largest IPO on the Shanghai Stock Exchange (SSE) and making Zhupao one of the most valuable technology companies in the world. Xu’s net worth increased to ¥60 billion based on his share ownership. 
In 2032, Xu launched Zhupao Campus as a private technology incubator, investing ¥15 billion of his net worth to support candidate ventures. In the first round of investments, Xu graduated five startups to Zhupao Campus, including Debtera Pharma and Sanial. Following a second round of investments in 2033, Xu created an AI innovation centre under the leadership of Efua Amankwah-Crouse in London City.
In July 2034, Xu was faced with calls to pull Zhupao’s support for Sanial after it was reported that the Chinese Communist Party (CCP) and Huawei had been testing early designs of implantable multielectrode arrays (MEAs) in the Xinjiang concentration camps, resulting in numerous cases of cerebral small vessel disease (CSVD) among the detainees. In a joint statement with Sanial founder and CEO Spencer Hagen, Xu claimed that Sanial only worked with consenting human volunteers for their trials with implantable MEAs, and that they had no involvement with the CCP’s activities in the camps.
In October 2036, Xu incorporated Sanial as a subsidiary of Zhupao. During a livestreamed conference, Xu unveiled the first neural colloid as a new class of implantable MEAs and “the biggest paradigm shift in consumer technology since smartphones.”  To demonstrate their effectiveness and ease-of-use, Xu personally injected a colloid while on stage and stated that it would take about 30 minutes for the colloid’s electrodes to migrate to his brain and ping a connection. Once they did, Xu was able to display a live montage of his cerebral cortex, claiming that the audience was “witnessing [his] consciousness down to the level of individual neurons.”
In May 2037, Sanial’s colloid design was reclassified by the State Administration for Market Regulation (SAMR) as a Class III implantable medical device (IMD), with the designation of “high-risk IMDs that pose potential risks to the human body and must be strictly controlled.” This ruling, which was attributed to ongoing frictions between Xu and the CCP, prompted international regulatory agencies to similarly adjust or suspend their pending IMD approvals of colloids. Xu was forced to cancel several contracts and partnerships for the manufacture of colloids, which led to a concurrent drop in Zhupao’s share price.
In June 2037, the SAMR fast-tracked a line of implantable MEAs developed by Huawei as a Class I IMD for “safe and effective routine administration.” In response, Xu accused the CCP of “favouritism,” claiming that it was misusing the SAMR classification process to give Huawei’s implantable MEA design a competitive edge over Sanial’s colloids. After a conversation with Chen, Xu also suspected Huawei of having obtained the proprietary specifications for colloids from the SAMR so they could be reverse engineered for Huawei’s own line of implantable MEAs. 
In November 2037, the CCP signed an agreement with Huawei as part of an initiative to introduce implantable MEAs to national sectors reliant on recording and stimulating neural activity. In response, Xu repeated his accusations against the CCP and hinted at legal action against Huawei for “intellectual property theft.” Subsequent to this, the CCP Beijing Xicheng District Committee, where Xu’s Party membership was registered, expelled him as a standing member on January 12th 2038 and placed him on a one-year probation, stating that he had “lost his Party spirit.”
Development of G6
In June 2038, colloids were approved by the Therapeutic Products Directorate (TPD) as a Class II IMD in a surprise ruling attributed to long-standing tensions between Huawei and Canada. Between July 2038 and May 2039, Zhupao worked with select physicians and hospitals across Canada to apply colloids to the neurostimulative diagnosis and treatment of various neurological disorders.
On December 8th 2039, Xu announced an agreement between Zhupao and the World Health Organisation (WHO) to manufacture and supply diagnostic colloids for the WHO’s contact tracing efforts to contain the spread of Cariappa-Muren disease (CMD). In the press briefing, Xu credited Hagen with having spearheaded the development of the diagnostic colloids, which were equipped with chemical sensors for the early detection of CMD-related breakdown products in brain tissue. 
In March 2040, Xu began to criticise the CCP for its treatment of epidemiologist Sunil Cariappa, who was in Beijing as part of a WHO mission to assist the National Health Commission (NHC) in charting the spread of CMD. On April 3rd 2040, Xu hosted a press event alongside Cariappa at Zhupao’s Shanghai headquarters, accusing the CCP of covering up its failings in addressing the CMD pandemic by “leveraging Cariappa’s name recognition to present China’s surveillance apparatus inside the wrapping of a necessary tool for biosecurity.” To dispel rumours that he was infected with CMD, Xu injected a diagnostic colloid at the start of his speech and showed a negative result 22 minutes later.
On April 7th 2040, former CCP General Secretary Xi Jinping accused Xu of “inciting subversion of state power” and ordered the Central Commission for Discipline Inspection (CCDI) to start an investigation for “violations of law and discipline.” On April 12th 2040, the CCDI declined to file a case against Xu owing to a concession between members of the Politburo as part of an internal power struggle. 
In May 2040, Xu entered Zhupao into a multilateral cooperation strategy being drawn up between the CCP and the WHO to “strengthen the national healthcare system, ensure that quality health services are delivered to the people, and enrich China’s contribution to global health and biosurveillance.”  On May 7th 2040, Xu organised a conference to officially unveil G6 as “a new WHO-endorsed network for biosurveillance, health informatics, and IMDs.” In September 2040, Xu presented the first version of G6 to an audience of officials from the CCP and the WHO.
On September 23rd 2040, Xu revealed a new line of colloids developed by Sanial that were being administered to Chinese citizens as part of a series of pilot programmes to introduce G6 to Guangdong, Sichuan, Yunnan, and Zhejiang provinces. Xu announced that the colloids supported both CMD-specific diagnostic sensors and a means of neurometric identification developed by Sanial.  After injecting one of the colloids himself, Xu obtained a second negative CMD diagnosis and linked his colloid to his Zhupay account for the purposes of user authentication.
On October 31st 2040, the CCP declared the G6 pilot programmes a success, announcing its intention to roll out the network under the name mìngyùn for all its territories and special economic zones (SEZs). In November 2040, Xu officially opened Zhupao’s new headquarters in Shanghai with a ceremony that included the activation of the building’s animated hologram of Zōng.
After the United Nations General Assembly (UNGA) adopted Resolution ES-13/6 on February 11th 2041, Xu joined a working group set up by the WHO to reorganise Zhupao’s G6 licensing tiers into a dedicated platform model. With the BRICS countries as early adopters, an increasing number of United Nations (UN) member states ratified G6-centric referendums and electoral campaigns in the spring and summer of 2041, resulting in Xu’s net worth surpassing ¥2 trillion. By the end of 2042, over 400 countries, corporations, and organisations along the Belt and Road Initiative (BRI) had licensed one or more G6 access tiers.
In August 2045, Xu organised a series of civil suits against Pokrov and its director Yuri Golitsyn, alleging that the company had illegally reverse engineered colloid technology, and that it had been developing and selling collocidals since 2042. In a public statement, Golitsyn denied any wrongdoing and condemned Xu for “deliberately misrepresenting the long-term risks of colloid implants.” In September 2045, all pending legal actions were unexpectedly dismissed, with rumours of an out-of-court settlement. 
In October 2045, Xu ordered an investigation to identify the source of a breach to Zhupao’s internal network, which had leaked proprietary G6 data to the public. The leak revealed that G6 had been heavily retrofitted with quantum neural networks (QNNs) between October 2040 and June 2041, which had not been disclosed to the public. On October 13th 2045, Xu responded by claiming the QNN retrofits were “imperative, given the amount of data that G6 is meant to process.” Xu also pointed to his suspicion of “Russian elements” being involved in the data leak.
In November 2047, Yuri accused Xu of “fearmongering” after G6 had misidentified a rise in cases of CSVD as the start of a second wave of the CMD pandemic. Xu responded by attributing the CSVD surge to Russia
‘s illicit market in colloids, which does not have access to Sanial’s licensed nanomaterials that prevent colloids from causing CSVD.
On February 20th 2049, Xu celebrated Zhupao’s 25th anniversary with a Silver Jubilee discount on all G6 licensing tiers, which led to an influx of requests and the largest one-day point gain in the history of the SSE. In March 2049, Xu called the electoral victory of Jagrati Thass a “grave mistake,” alluding to Thass’ campaign promise to withdraw India from G6.
During a press conference to celebrate the launch of Omnipedia, Xu was asked whether he expected the trend of G6 licensees questioning their memberships to continue. Xu replied by listing off the network’s accomplishments and encouraged all nations to embrace G6, stating that “it continues to be our wall against the next wave of CMD. The more countries contribute, the better G6 becomes. We need to do this because that is how the system works. That is how it will save us all.”
On July 10th 2042, Xu married Zhenxi Hai, the daughter of a former deputy governor of Yunnan province. They have one child together, a daughter named Xuejing (born in 2044). Xu
currently lives in Shanghai, though he often spends time in his penthouse in the Shard. Xu is repeatedly ranked as the most powerful person in the world by Forbes and other publications, receiving numerous awards and honorary degrees.
Xu’s personal wealth of ¥6.45 trillion
comes from his 10% stake in Zhupao and other business interests. He frequently donates to charitable foundations and environmental causes. He owns property in Beijing, Colombo, London City, Shanghai, and Xianggang.
is a fan of heavy metal, often naming Polysemic Sortilege as his favourite band. He reportedly received an unedited pre-release version of Efrim Waite’s controversial second solo album, Of Altars & Graves & Sacrifices in 2033.
- Kierney, L. (June 2031). “The Makings of a Maverick: Xu Shaoyong’s Rise to Power.” Forbes. ↩
- Ren, D. (September 2026). “Interview: Xu Shaoyong highlights Zhupao’s business strategies.” Caixin Global. ↩
- Chang, E. (May 2031). “From BAT to BATZ: How Zhupao joined the ranks of Baidu, Alibaba, and Tencent.” China Daily. ↩
- Renyaan, W. (October 2036). “Colloid implants set to shift smartphones from devices you have to devices you are.” Wired. ↩
- Lim, X. (May 2037). “Zhupao founder Xu Shaoyong ‘repeatedly ignored warnings’ from CEO Chen Lei about Communist Party.” South China Morning Post. ↩
- Muren, C; Hagen, S; Gao, K et al. (November 2033). “Electrode implant-based ultra-sensitive array for PrP detection in brain tissue.” Nature Nanotechnology. ↩
- Ivanova, P. (October 2044). “Cariappa-Muren disease hollowed out the Chinese state. Now Zhupao wears it as a mask.” The Guardian. ↩
- World Health Organisation. (May 2040). “China-WHO Country Cooperation Strategy 2041-2045.” WHO Regional Office for the Western Pacific. ↩
- Ruiz-Blondet, M; Jin, Z; Laszlo, S. (July 2016). “A Novel Method for Very High Accuracy Event-Related Potential Biometric Identification.” IEEE Signal Processing Society. ↩
- Hesske, A. (September 2045). “Yearslong feud between Xu Shaoyong and Yuri Golitsyn escalates to legal action.” Insider. ↩